Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Animal Type
3.2. Snippet by Ingredient
3.3. Snippet by Form
3.4. Snippet by Distribution Channel
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Growth in Pet Ownership and Humanization of Pets
4.1.1.2. Strategies Adopted by the Companies
4.1.2. Restraints
4.1.2.1. Stringent Regulatory Framework
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. By Animal Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
6.1.2. Market Attractiveness Index, By Animal Type
6.2. Livestock Animals*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Cattle
6.2.4. Poultry
6.2.5. Swine
6.2.6. Horses
6.2.7. Others
6.3. Companion Animals
6.3.1. Dogs
6.3.2. Cats
6.3.3. Birds
6.3.4. Other Small Mammals
7. By Ingredient
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
7.1.2. Market Attractiveness Index, By Ingredient
7.2. Vitamins & Minerals*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Amino Acids
7.4. Omega Fatty Acids
7.5. Probiotics & Prebiotics
7.6. Botanicals
7.7. Others
8. By Form
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
8.1.2. Market Attractiveness Index, By Form
8.2. Powder*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Liquid
8.4. Tablets/Capsules
8.5. Injections
9. By Distribution Channel
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Online Retailers*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Pet Stores
9.4. Veterinary Clinics
9.5. Convenience Stores
9.6. Supermarkets/Hypermarkets
9.7. Pharmacies and Drug Stores
9.8. Other Distribution Channels
10. Sustainability Analysis
10.1. Environmental Analysis
10.2. Economic Analysis
10.3. Governance Analysis
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. BESTI*
12.1.1. Company Overview
12.1.2. Type Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Ultra Premium Direct
12.3. SASU Alodis
12.4. Zolux Group (Laboratoire Francodex)
12.5. Reverdy Equine Nutrition
12.6. Equi Well-being (EQUI BIEN-ETRE)
12.7. Virbac S.A.
12.8. Nestl? S.A. (Nestl? France)
12.9. Mars, Incorporated (Mars France)
12.10. Health and Happiness (H&H) International Holdings Limited (Zesty Paws FR)
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us